Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Novartis gives Vasella honorary role as payout row continues

Named honorary chairman chairman at Swiss pharma firm after stepping down as chairman

- PMLiVE

Second approval in US for Bayer-Onyx’ Stivarga

FDA clears drug to treat patients with gastrointestinal stromal tumours

- PMLiVE

EMA application fees set for slower rise in 2013

European regulator expects rate to increase by 2.6 per cent

- PMLiVE

Takeda-Affymax recall Omontys in US after deaths

Severe allergic reactions reported in kidney disease patients taking anaemia drug

- PMLiVE

Former Glaxo CEO Ernest Mario to chair Chimerix

Pharma veteran has previously also served as CEO of Alza and Reliant

- PMLiVE

Evidence: The unmet need

Only through change can the pharma industry align its products with the unmet needs of payers

- PMLiVE

Service sector salary survey: the results

Following last month's analysis of pharma salaries, we bring you the results from those working on the service side of the healthcare industry

- PMLiVE

Virgo Health opens New York and Singapore offices

Susan Cuozzo will head the US team and Rachel Norager the Singapore team

- PMLiVE

Royalty Pharma mulls bid for Elan

Follows Biogen’s $3.25bn acquisition of Tysabri from Elan

Roche - Basel

Roche’s Herceptin follow-up cleared in US

FDA approval for Kadcyla (formerly T-DM1) in breast cancer

- PMLiVE

Late-stage failure for Merck’s cilengitide in brain cancer

Integrin inhibitor unable to improve overall survival in phase III trials

- PMLiVE

Swedish regulator rules Boehringer press release is advertising

German pharma company fails to appeal decision

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links